Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines

被引：22

作者：

Botton, Jeremie ^{[1
,2
,3
]}

Dray-Spira, Rosemary ^{[1
,2
]}

Baricault, Berangere ^{[1
,2
]}

Drouin, Jerome ^{[1
,2
]}

Bertrand, Marion ^{[1
,2
]}

Jabagi, Marie-Joelle ^{[1
,2
]}

Weill, Alain ^{[1
,2
]}

Zureik, Mahmoud ^{[1
,2
,4
]}

机构：

[1] French Natl Agcy Safety Med & Hlth Prod, EPI PHARE Sci Interest Grp Epidemiol Hlth Prod, St Denis, France

[2] French Natl Hlth Insurance, St Denis, France

[3] Univ Paris Saclay, Fac Pharm, F-92296 Chatenay Malabry, France

[4] Univ Paris Saclay, Antiinfect Evas & Pharmacoepidemiol, CESP, UVSQ,Univ Paris Sud,INSERM, F-78180 Montigny Le Bretonneux, France

来源：

VACCINE | 2022年 / 40卷 / 03期

关键词：

COVID-19; Effectiveness; Epidemiology; Public Health; Vaccine;

D O I：

10.1016/j.vaccine.2021.12.009

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Randomized clinical trials have shown mRNA-based vaccines to be 92-95% effective to prevent COVID-19 in adults. We aimed to estimate the impact of vaccination on the risk of severe COVID-19 (requiring hospitalization) in elderly people. Each 1,422,461 vaccinated subject aged 75 or older was matched to two unvaccinated subjects of same age, sex, administrative region, and type of residence. They were followed from date of first injection between 27 December 2020 and 24 February 2021 to 20 March 2021 for COVID-19 hospitalization. Mean age was 82.4 years (SD, 5.7) and median follow-up was 38 days [IQR, 17-54]. Adjusted Hazard Ratio for COVID-19 hospitalization from day 7 after the second dose was estimated at 0.14 (95% confidence interval, 0.11-0.17), i.e. an estimated 86% risk reduction in people aged 75 and older, highlighting the major impact of mRNA vaccination on reducing the risk of COVID-19 among elderly people. (C) 2021 Published by Elsevier Ltd.

引用

页码：414 / 417

页数：4

共 10 条

[1] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].

Baden, Lindsey R. ;

El Sahly, Hana M. ;

Essink, Brandon ;

Kotloff, Karen ;

Frey, Sharon ;

Novak, Rick ;

Diemert, David ;

Spector, Stephen A. ;

Rouphael, Nadine ;

Creech, C. Buddy ;

McGettigan, John ;

Khetan, Shishir ;

Segall, Nathan ;

Solis, Joel ;

Brosz, Adam ;

Fierro, Carlos ;

Schwartz, Howard ;

Neuzil, Kathleen ;

Corey, Larry ;

Gilbert, Peter ;

Janes, Holly ;

Follmann, Dean ;

Marovich, Mary ;

Mascola, John ;

Polakowski, Laura ;

Ledgerwood, Julie ;

Graham, Barney S. ;

Bennett, Hamilton ;

Pajon, Rolando ;

Knightly, Conor ;

Leav, Brett ;

Deng, Weiping ;

Zhou, Honghong ;

Han, Shu ;

Ivarsson, Melanie ;

Miller, Jacqueline ;

Zaks, Tal .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416

[2] Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study [J].

Bernal, Jamie Lopez ;

Andrews, Nick ;

Gower, Charlotte ;

Robertson, Chris ;

Stowe, Julia ;

Tessier, Elise ;

Simmons, Ruth ;

Cottrell, Simon ;

Roberts, Richard ;

O'Doherty, Mark ;

Brown, Kevin ;

Cameron, Claire ;

Stockton, Diane ;

McMenamin, Jim ;

Ramsay, Mary .

BMJ-BRITISH MEDICAL JOURNAL, 2021, 373

[3] Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study [J].

Chung, Hannah ;

He, Siyi ;

Nasreen, Sharifa ;

Sundaram, Maria E. ;

Buchan, Sarah A. ;

Wilson, Sarah E. ;

Chen, Branson ;

Calzavara, Andrew ;

Fell, Deshayne B. ;

Austin, Peter C. ;

Wilson, Kumanan ;

Schwartz, Kevin L. ;

Brown, Kevin A. ;

Gubbay, Jonathan B. ;

Basta, Nicole E. ;

Mahmud, Salaheddin M. ;

Righolt, Christiaan H. ;

Svenson, Lawrence W. ;

MacDonald, Shannon E. ;

Janjua, Naveed Z. ;

Tadrous, Mina ;

Kwong, Jeffrey C. .

BMJ-BRITISH MEDICAL JOURNAL, 2021, 374

[4] BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting [J].

Dagan, Noa ;

Barda, Noam ;

Kepten, Eldad ;

Miron, Oren ;

Perchik, Shay ;

Katz, Mark A. ;

Hernan, Miguel A. ;

Lipsitch, Marc ;

Reis, Ben ;

Balicer, Ran D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) :1412-1423

[5] Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data [J].

Haas, Eric J. ;

Angulo, Frederick J. ;

McLaughlin, John M. ;

Anis, Emilia ;

Singer, Shepherd R. ;

Khan, Farid ;

Brooks, Nati ;

Smaja, Meir ;

Mircus, Gabriel ;

Pan, Kaijie ;

Southern, Jo ;

Swerdlow, David L. ;

Jodar, Luis ;

Levy, Yeheskel ;

Alroy-Preis, Sharon .

LANCET, 2021, 397 (10287) :1819-1829

[6] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine [J].

Polack, Fernando P. ;

Thomas, Stephen J. ;

Kitchin, Nicholas ;

Absalon, Judith ;

Gurtman, Alejandra ;

Lockhart, Stephen ;

Perez, John L. ;

Perez Marc, Gonzalo ;

Moreira, Edson D. ;

Zerbini, Cristiano ;

Bailey, Ruth ;

Swanson, Kena A. ;

Roychoudhury, Satrajit ;

Koury, Kenneth ;

Li, Ping ;

Kalina, Warren V. ;

Cooper, David ;

Frenck, Robert W., Jr. ;

Hammitt, Laura L. ;

Tureci, Ozlem ;

Nell, Haylene ;

Schaefer, Axel ;

Unal, Serhat ;

Tresnan, Dina B. ;

Mather, Susan ;

Dormitzer, Philip R. ;

Sahin, Ugur ;

Jansen, Kathrin U. ;

Gruber, William C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) :2603-2615

[7] Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people [J].

Semenzato, Laura ;

Botton, Jeremie ;

Drouin, Jerome ;

Cuenot, Francois ;

Dray-Spira, Rosemary ;

Weill, Alain ;

Zureik, Mahmoud .

LANCET REGIONAL HEALTH-EUROPE, 2021, 8

[8] Antihypertensive Drugs and COVID-19 Risk A Cohort Study of 2 Million Hypertensive Patients [J].

Semenzato, Laura ;

Botton, Jeremie ;

Drouin, Jerome ;

Baricault, Berangere ;

Vabre, Clementine ;

Cuenot, Francois ;

Penso, Laetitia ;

Herlemont, Philippe ;

Sbidian, Emilie ;

Weill, Alain ;

Dray-Spira, Rosemary ;

Zureik, Mahmoud .

HYPERTENSION, 2021, 77 (03) :833-842

[9] Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study [J].

Tartof, Sara Y. ;

Slezak, Jeff M. ;

Fischer, Heidi ;

Hong, Vennis ;

Ackerson, Bradley K. ;

Ranasinghe, Omesh N. ;

Frankland, Timothy B. ;

Ogun, Oluwaseye A. ;

Zamparo, Joann M. ;

Gray, Sharon ;

Valluri, Srinivas R. ;

Pan, Kaije ;

Angulo, Frederick J. ;

Jodar, Luis ;

McLaughlin, John M. .

LANCET, 2021, 398 (10309) :1407-1416

[10] Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021 [J].

Tenforde, Mark W. ;

Olson, Samantha M. ;

Self, Wesley H. ;

Talbot, H. Keipp ;

Lindsell, Christopher J. ;

Steingrub, Jay S. ;

Shapiro, Nathan, I ;

Ginde, Adit A. ;

Douin, David J. ;

Prekker, Matthew E. ;

Brown, Samuel M. ;

Peltan, Ithan D. ;

Gong, Michelle N. ;

Mohamed, Amira ;

Khan, Akram ;

Aline, Matthew C. ;

Files, D. Clark ;

Gibbs, Kevin W. ;

Stubblefield, William B. ;

Casey, Jonathan D. ;

Rice, Todd W. ;

Grijalva, Carlos G. ;

Hager, David N. ;

Shehu, Arber ;

Qadir, Nida ;

Chang, Steven Y. ;

Wilson, Jennifer G. ;

Gaglani, Manjusha ;

Murthy, Kempapura ;

Calhoun, Nicole ;

Monto, Arnold S. ;

Martin, Emily T. ;

Malani, Anurag ;

Zimmerman, Richard K. ;

Silveira, Fernanda P. ;

Middleton, Donald B. ;

Zhu, Yuwei ;

Wyatt, Dayna ;

Stephenson, Meagan ;

Baughman, Adrienne ;

Womack, Kelsey N. ;

Hart, Kimberly W. ;

Kobayashi, Miwako ;

Verani, Jennifer R. ;

Patel, Manish M. .

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (18) :674-679

← 1 →